CA Stock MarketDetailed Quotes

Waverley Pharma Inc (WAVE)

Watchlist
  • 0.030
  • 0.0000.00%
15min DelayTrading Jan 20 16:00 ET
1.62MMarket Cap-3.00P/E (TTM)

Waverley Pharma Inc (WAVE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
4,595.53%1.05M
385.6K
391.34K
15.36%475.37K
43.34%452.96K
-93.83%22.42K
0
0
-66.95%412.09K
76.30%316K
Operating revenue
4,595.53%1.05M
--385.6K
--391.34K
15.36%475.37K
43.34%452.96K
-93.83%22.42K
--0
--0
-66.95%412.09K
76.30%316K
Cost of revenue
8,294.33%657.7K
201.68K
249.05K
-21.35%261.33K
-2.82%253.49K
-96.66%7.84K
0
0
-65.50%332.29K
78.14%260.85K
Gross profit
2,608.14%394.9K
183.93K
142.29K
168.22%214.04K
261.61%199.46K
-88.66%14.58K
0
0
-71.88%79.8K
68.08%55.16K
Operating expense
-23.39%592.59K
-42.93%173.69K
-28.26%161.9K
-27.10%957.62K
-29.13%714.14K
-19.53%773.49K
-7.23%304.35K
-31.02%225.67K
42.49%1.31M
253.04%1.01M
Selling and administrative expenses
56.57%579.48K
26.08%172.89K
0.47%161.59K
-42.17%652.34K
-34.23%580.18K
-53.18%370.11K
-49.53%137.13K
-41.09%160.83K
-0.90%1.13M
207.53%882.21K
Research and development costs
-96.75%13.11K
-99.52%800
-99.52%313
80.60%423.66K
44.65%252.34K
136.31%403.38K
196.48%167.22K
19.71%64.84K
187.28%234.58K
181.82%174.45K
Other taxes
----
----
----
-141.83%-118.38K
----
----
----
----
83.57%-48.95K
----
Operating profit
73.95%-197.69K
103.36%10.23K
91.31%-19.61K
39.74%-743.57K
45.97%-514.68K
8.85%-758.91K
-34.71%-304.35K
30.64%-225.67K
-93.35%-1.23M
-277.06%-952.54K
Net non-operating interest income (expenses)
-18.87%-131.85K
-16.39%-42.68K
-26.44%-41.02K
-111.87%-162.41K
-114.55%-120.59K
-133.34%-110.92K
-138.51%-36.67K
-176.87%-32.44K
-360.71%-76.65K
-470.50%-56.21K
Non-operating interest income
----
----
----
-29.24%1.08K
----
----
----
----
--1.52K
----
Non-operating interest expense
18.87%131.85K
16.39%42.68K
26.44%41.02K
111.37%162.54K
113.85%120.72K
133.34%110.92K
--36.67K
176.87%32.44K
--76.9K
--56.45K
Total other finance cost
----
----
----
-26.10%943
----
----
----
----
-92.33%1.28K
----
Other net income (expenses)
343.13%29.26K
220.82%4.61K
507.98%24.55K
95.50%-41.1K
95.70%-38.89K
-16.77%-12.04K
-1,198.85%-3.81K
-142.13%-6.02K
-9,741.75%-913.51K
-1,741.90%-905.34K
Gain on sale of security
343.13%29.26K
220.82%4.61K
507.98%24.55K
-7,010.55%-41.1K
-612.30%-38.89K
-16.77%-12.04K
-1,198.85%-3.81K
-142.13%-6.02K
93.77%-578
-86.23%7.59K
Special income (charges)
----
----
----
--0
----
----
----
----
---942.62K
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--942.62K
----
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
--29.69K
----
Income before tax
65.95%-300.28K
91.93%-27.84K
86.34%-36.08K
57.42%-947.08K
64.78%-674.17K
0.97%-881.87K
-43.11%-344.83K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
Income tax
1.63K
0
Earnings from equity interest net of tax
Net income
65.77%-301.91K
91.93%-27.84K
86.34%-36.08K
57.42%-947.08K
64.78%-674.17K
0.97%-881.87K
-43.11%-344.83K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
Net income continuous operations
65.77%-301.91K
91.93%-27.84K
86.34%-36.08K
57.42%-947.08K
64.78%-674.17K
0.97%-881.87K
-43.11%-344.83K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
Noncontrolling interests
Net income attributable to the company
65.77%-301.91K
91.93%-27.84K
86.34%-36.08K
57.42%-947.08K
64.78%-674.17K
0.97%-881.87K
-43.11%-344.83K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
65.77%-301.91K
91.93%-27.84K
86.34%-36.08K
57.42%-947.08K
64.78%-674.17K
0.97%-881.87K
-43.11%-344.83K
22.21%-264.13K
-234.91%-2.22M
-823.20%-1.91M
Diluted earnings per share
50.00%-0.01
0
0
50.00%-0.02
66.67%-0.01
0.00%-0.02
-124.11%-0.01
0
-300.00%-0.04
-0.03
Basic earnings per share
50.00%-0.01
0
0
50.00%-0.02
66.67%-0.01
0.00%-0.02
-124.11%-0.01
0
-300.00%-0.04
-0.03
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 4,595.53%1.05M385.6K391.34K15.36%475.37K43.34%452.96K-93.83%22.42K00-66.95%412.09K76.30%316K
Operating revenue 4,595.53%1.05M--385.6K--391.34K15.36%475.37K43.34%452.96K-93.83%22.42K--0--0-66.95%412.09K76.30%316K
Cost of revenue 8,294.33%657.7K201.68K249.05K-21.35%261.33K-2.82%253.49K-96.66%7.84K00-65.50%332.29K78.14%260.85K
Gross profit 2,608.14%394.9K183.93K142.29K168.22%214.04K261.61%199.46K-88.66%14.58K00-71.88%79.8K68.08%55.16K
Operating expense -23.39%592.59K-42.93%173.69K-28.26%161.9K-27.10%957.62K-29.13%714.14K-19.53%773.49K-7.23%304.35K-31.02%225.67K42.49%1.31M253.04%1.01M
Selling and administrative expenses 56.57%579.48K26.08%172.89K0.47%161.59K-42.17%652.34K-34.23%580.18K-53.18%370.11K-49.53%137.13K-41.09%160.83K-0.90%1.13M207.53%882.21K
Research and development costs -96.75%13.11K-99.52%800-99.52%31380.60%423.66K44.65%252.34K136.31%403.38K196.48%167.22K19.71%64.84K187.28%234.58K181.82%174.45K
Other taxes -------------141.83%-118.38K----------------83.57%-48.95K----
Operating profit 73.95%-197.69K103.36%10.23K91.31%-19.61K39.74%-743.57K45.97%-514.68K8.85%-758.91K-34.71%-304.35K30.64%-225.67K-93.35%-1.23M-277.06%-952.54K
Net non-operating interest income (expenses) -18.87%-131.85K-16.39%-42.68K-26.44%-41.02K-111.87%-162.41K-114.55%-120.59K-133.34%-110.92K-138.51%-36.67K-176.87%-32.44K-360.71%-76.65K-470.50%-56.21K
Non-operating interest income -------------29.24%1.08K------------------1.52K----
Non-operating interest expense 18.87%131.85K16.39%42.68K26.44%41.02K111.37%162.54K113.85%120.72K133.34%110.92K--36.67K176.87%32.44K--76.9K--56.45K
Total other finance cost -------------26.10%943-----------------92.33%1.28K----
Other net income (expenses) 343.13%29.26K220.82%4.61K507.98%24.55K95.50%-41.1K95.70%-38.89K-16.77%-12.04K-1,198.85%-3.81K-142.13%-6.02K-9,741.75%-913.51K-1,741.90%-905.34K
Gain on sale of security 343.13%29.26K220.82%4.61K507.98%24.55K-7,010.55%-41.1K-612.30%-38.89K-16.77%-12.04K-1,198.85%-3.81K-142.13%-6.02K93.77%-578-86.23%7.59K
Special income (charges) --------------0-------------------942.62K----
-Less:Impairment of capital assets --------------0------------------942.62K----
Other non-operating income (expenses) ----------------------------------29.69K----
Income before tax 65.95%-300.28K91.93%-27.84K86.34%-36.08K57.42%-947.08K64.78%-674.17K0.97%-881.87K-43.11%-344.83K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M
Income tax 1.63K0
Earnings from equity interest net of tax
Net income 65.77%-301.91K91.93%-27.84K86.34%-36.08K57.42%-947.08K64.78%-674.17K0.97%-881.87K-43.11%-344.83K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M
Net income continuous operations 65.77%-301.91K91.93%-27.84K86.34%-36.08K57.42%-947.08K64.78%-674.17K0.97%-881.87K-43.11%-344.83K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M
Noncontrolling interests
Net income attributable to the company 65.77%-301.91K91.93%-27.84K86.34%-36.08K57.42%-947.08K64.78%-674.17K0.97%-881.87K-43.11%-344.83K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 65.77%-301.91K91.93%-27.84K86.34%-36.08K57.42%-947.08K64.78%-674.17K0.97%-881.87K-43.11%-344.83K22.21%-264.13K-234.91%-2.22M-823.20%-1.91M
Diluted earnings per share 50.00%-0.010050.00%-0.0266.67%-0.010.00%-0.02-124.11%-0.010-300.00%-0.04-0.03
Basic earnings per share 50.00%-0.010050.00%-0.0266.67%-0.010.00%-0.02-124.11%-0.010-300.00%-0.04-0.03
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More